The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
风险的独立预测因子。然而,关于 T2DM患者肝酶升高的临床数据很少。近期《Diabetes ObesMetab》发表了一篇德国学者的相关研究,作者假设T2DM患者的肝酶升高可以作为糖尿病相关并发症风险
写了篇动态血糖仪的临床试验文章,从没投过ISC,想试试,DIABETES TECHNOLOGY & THERAPEUTICS这个杂志怎么样?
了其在降糖和改善患者心肾预后方面的作用。卡格列净心血管评估研究(CANVAS)指出,与安慰剂相比,卡格列净可减少T2DM患者的痛风发作次数。而《Diabetes Obes Metab》今年发表的一篇
概述成人隐匿性自身免疫糖尿病,是Ⅰ型糖尿病的一种特殊类型,属于自身免疫性疾病,与Ⅰ型糖尿病的自身免疫发病机制相同,以胰岛B细胞呈缓慢性破坏为主。本病虽然处在Ⅰ型糖尿病的范畴,但它的起病又具有隐置、迟发
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright
The Foot in Diabetes. Third Edition. Edited by A.J.M. Boulton, H. Connor, P.R. Cavanagh. Copyright